2022 MACH-Track Cohort
We are delighted to announce our second cohort of MACH-Track trainees who will commence in 2022. In their first year, trainees will continue their clinical specialty training and at the same time, undertake a number of mini-projects in preparation for their PhD years starting in 2023.
We will be sharing the latest updates on their work in our newsletters, on Twitter and on our website.
2022 MACH-Track cohort pictured with Professor Sir John Savill (Plus Dr Megan Ball)
Meet our 2022 MACH-Track trainees
-
Dr Megan Ball
Dr Ball completed her undergraduate degree in Biomedical Science at Bond University in Queensland and subsequently completed a Doctor of Medicine with Distinction at Flinders University in South Australia.
She is currently in her first year of Advanced Training in Clinical Genetics/Metabolic Medicine and General Paediatrics at the Women’s and Children’s Hospital in Adelaide.
Dr Ball hopes to improve the clinical journey for children with complex and life-limiting illnesses such as inborn errors of metabolism and has a particular interest in mitochondrial disorders.
She will begin working as a Clinical Genetics Fellow at the Murdoch Children’s Research Institute in 2022 and will use the opportunity to further investigate the molecular diagnosis of rare diseases.
-
Dr Luke Fletcher
Dr Fletcher is an Anaesthesia trainee and works primarily at Austin Health.
He has completed a Bachelor of Medicine, Bachelor of Surgery (Hons), Bachelor of Medical Sciences (Hons) and Masters of Perioperative Medicine at Monash University in Victoria.
Dr Fletcher has a keen interest in pulmonary hypertension and right ventricular dysfunction, which are strongly associated with perioperative morbidity and mortality.
He hopes to develop advanced haemodynamic monitoring technologies to better support patients with these conditions throughout their surgical journey and improve patient-centred outcomes.
-
Dr Jason Ha
Dr Ha is a Bachelor of Medicine, Bachelor of Surgery (Honours) graduate of Monash University, during which he undertook an intercalated Bachelor of Medical Sciences (Honours) at the Centre for Eye Research Australia.
Dr Ha is currently an unaccredited Ophthalmology Registrar and has been selected to embark on the RANZCO Vocational Training Pathway at the Royal Victorian Eye and Ear Hospital in 2022.
Dr Ha is passionate about utilising new technologies and artificial intelligence to enhance patient care, improve access to eye care, and preserve and restore sight.
-
Dr Michael Moso
Dr Moso completed his medical degree at Monash University in 2015, graduating with first class honours.
He also completed a Bachelor of Medical Science (Honours) degree during his medical training and undertook research in HIV latency at the Burnet Institute and the Peter Doherty Institute with the Lewin laboratory.
Dr Moso completed his internship, basic physician training and first year of advanced training in Infectious Diseases at the Alfred Hospital.
He is currently completing his second year of Infectious Diseases training at the Royal Melbourne Hospital with the Victorian Infectious Diseases Service.
Dr Moso enjoys the challenges of managing a variety of infectious diseases including HIV and is interested in investigating mechanisms of HIV persistence, latency reversal and HIV cure.
-
Dr Farrah Rodrigues
Dr Rodrigues is a Paediatric Endocrinology Fellow at the Royal Children’s Hospital.
She has completed a Bachelor of Science, Postgraduate Diploma in Science at the University of Auckland, and a Bachelor of Medicine and Bachelor of Surgery at the University of Notre Dame.
Dr Rodrigues is training in Paediatric Endocrinology and General Paediatrics at the Royal Children’s and Monash Children’s Hospital.
She has also spent some time working at the Royal Darwin Hospital to gain experience in rural and remote paediatric care and indigenous health.
Dr Rodrigues sees patients with disorders related to hormone dysfunction such diabetes and thyroid disorders, but also includes other conditions leading to abnormal growth and pubertal development.
She has a particular interest in diabetes and the late endocrine effects of childhood cancer treatment.
